Antidepressant Recall Expands Across the U.S.
FDA recalls duloxetine bottles after tests found elevated levels of possible cancer-causing impurity.
Sara is a credited writer, editor, contributor, and essayist, as well as a novelist and poet with more than two decades of experience in media arts. A seasoned publishing professional, she's worked for newspapers, magazines and book publishers in content digitization, editorial, acquisitions and intellectual property. Sara is a member of the International Association of Writers & Editors, has received numerous awards and has been an invited speaker at a Careers in Publishing & Authorship event at Michigan State University and a Reading and Writing Instructor at Sylvan Learning Center. She is also a mental health therapist, clinical supervisor and entrepreneur, holding an MBA degree with a concentration in Marketing and an MA in Clinical Mental Health Counseling (graduating with a 4.2/4.0 GPA). Additionally, she is a member of Chi Sigma Iota, was on her local chapter's board, and a 2020 recipient of the Donald D. Davis scholarship recognizing social responsibility. Sara is certified in children's book writing, HTML coding and social media marketing. Her nine books can be found on Amazon.
FDA recalls duloxetine bottles after tests found elevated levels of possible cancer-causing impurity.
FDA warns recalled Alfredo sauce issue may be even more serious.
Study finds psilocybin may ease suicidal thoughts and depression for months after treatment.
FDA recalls several Alyacen birth control lots after tests found unacceptable impurity levels.
Packaging error leads to recall after stronger blood pressure capsules found in mislabeled boxes.
Federal case exposes a member of an online network accused of exploiting vulnerable minors.
Federal agency seeks dismissal of the NAACP’s pollution case against xAI.
Family alleges poor supervision led to injury, punishment and lasting harm at school.
Kraft Heinz faces recall involving a common household staple.
Federal judge permanently dismisses xAI lawsuit accusing OpenAI of stealing trade secret.